Burlington, Mass.-based Tufts Medicine recorded an operating loss of $31.8 million (-4.2% operating margin) in the first quarter of 2026, down from an operating loss of $28.9 million (-4.1% margin) during the same period last year, according to its Feb. 2 financial report.
The system reported total operating revenue of $760.4 million for the three months ended Dec. 31, up from $710.7 million during the same period last year. Patient service revenue totaled $594.1 million, up from $574 million.
Total operating expenses were $792.2 million in the quarter, up from $739.7 million last year. Salaries, wages and employee benefits totaled $422.2 million, up from $392.8 million. Supplies and other expenses were $224 million, up from $192.2 million.
Tufts Medicine reported a net loss of $35.6 million in the quarter, down from a net loss $26.6 million last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
